Michael Yee (Jeff Rumans for Endpoints News)
After monthslong lull, Big Pharma should be ready to pounce on M&A as market settles — analysts
Those who have been longing for the return of merger Mondays may not have to wait that much longer.
That’s according to Jefferies analysts, who …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
